These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9071946

  • 21. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM, Brzezinski A, Lashner BA.
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [Abstract] [Full Text] [Related]

  • 22. Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
    Singleton JW, Hanauer S, Robinson M.
    Dig Dis Sci; 1995 May; 40(5):931-5. PubMed ID: 7729281
    [Abstract] [Full Text] [Related]

  • 23. Is maintenance therapy effective in Crohn's disease?
    Greenberger NJ, Miner PB.
    Lancet; 1994 Oct 01; 344(8927):900-1. PubMed ID: 7934340
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Maintenance strategies in Crohn's disease.
    Sachar DB.
    Hosp Pract (1995); 1996 Jan 15; 31(1):99-106. PubMed ID: 8595995
    [Abstract] [Full Text] [Related]

  • 29. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
    Tremaine WJ.
    Gastroenterology; 1992 Aug 15; 103(2):694-6. PubMed ID: 1353043
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.
    Brignola C, Cottone M, Pera A, Ardizzone S, Scribano ML, De Franchis R, D'Arienzo A, D'Albasio G, Pennestri D.
    Gastroenterology; 1995 Feb 15; 108(2):345-9. PubMed ID: 7835575
    [Abstract] [Full Text] [Related]

  • 33. Nongranulomatous interstitial lung disease in Crohn's disease.
    Hotermans G, Benard A, Guenanen H, Demarcq-Delerue G, Malart T, Wallaert B.
    Eur Respir J; 1996 Feb 15; 9(2):380-2. PubMed ID: 8777981
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E, Bock H.
    Leber Magen Darm; 1988 Apr 15; 18(2):104-13. PubMed ID: 3374251
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Second trial of mesalamine therapy in the treatment of active Crohn's disease.
    Singleton J.
    Gastroenterology; 1994 Aug 15; 107(2):632-3. PubMed ID: 8039647
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease].
    Del Corso L, Moruzzo D, Romanelli AM, Norpoth M, Pentimone F, Bresci G.
    Dtsch Med Wochenschr; 1995 Dec 15; 120(50):1723-7. PubMed ID: 8542807
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.